Overexpression of functional human FLT3 ligand in Pichia pastoris

被引:0
|
作者
E. Karimi
H. Faraji
D. Hamidi Alamdari
M. Souktanloo
M. Mojarrad
L. K. Ashman
B. Mashkani
机构
[1] Mashhad University of Medical Sciences,Department of Medical Biochemistry, School of Medicine
[2] Mashhad University of Medical Sciences,Department of Medical Biotechnology, School of Medicine
[3] Mashhad University of Medical Sciences,Department of Medical Genetics, School of Medicine
[4] University of Newcastle,Department of Medical Biochemistry, School of Biomedical Sciences and Pharmacy
[5] Hormozgan University of Medical Sciences,Department of Laboratory Sciences, Faculty of Paramedicine
来源
关键词
recombinant protein production; codon optimization; biological activity; FLT3 ligand; methanol induction;
D O I
暂无
中图分类号
学科分类号
摘要
Growth factors and cytokines including FLT3 Ligand (FLT3L) have many applications in cellular and molecular biology studies, and also as therapeutical agents. FLT3L was expressed in Pichia pastoris through cloning from human leukemic K562 cell line as well as using a codon-optimized synthetic construct. Codon adaptation index (CAI) was increased from 55 in the native sequence up to 95 after optimization. Significant changes occurred in the codons for Pro, Arg, Leu and Ser toward the favored codons in P. pastoris. Both forms of expressed FLT3L (from the native and optimized sequences) were capable of stimulating proliferation of the FDC-P1 cells expressing human wild-type FLT3 (FD–FLT3–WT). Sequence optimization resulted in 55-fold increase in the yield of active FLT3L (290 μg/mL of product in the crude supernatant). Amino acid residues 27–162 are sufficient for the biological function of human FLT3L. Pichia pastoris is a highly efficient and cost-effective system for expression of endotoxin-free FLT3L; however, codon optimization is necessary for its optimal expression.
引用
收藏
页码:421 / 428
页数:7
相关论文
共 50 条
  • [31] Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-CSF
    Daro, E
    Butz, E
    Smith, J
    Teepe, M
    Maliszewski, CR
    McKenna, HJ
    CYTOKINE, 2002, 17 (03) : 119 - 130
  • [32] Cloning and sequencing of ovine Flt3 ligand
    Chan, S. S. M.
    Lyons, N.
    McConnell, I.
    Blacklaws, B. A.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2007, 34 (03) : 167 - 171
  • [33] THE LIGAND FOR FLT3/FLK2
    HANNUM, C
    CULPEPPER, J
    CAMPBELL, D
    MCCLANAHAN, T
    DUDA, G
    ZURAWSKI, S
    RENNICK, D
    WAGNER, J
    MARTINA, N
    KASTELEIN, R
    SHANAFELT, A
    PETERSON, D
    MENON, S
    DANG, W
    MATTSON, J
    LUH, J
    BAZAN, F
    ROSNET, O
    DUBREUIL, P
    BIRNBAUM, D
    LEE, F
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 19 - 19
  • [34] Understanding and overcoming FLT3 ligand-mediated Resistance to Type II FLT3 Inhibitors
    Alqahtani, Taha
    MacEwan, David
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (02) : 406 - 406
  • [35] FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease
    Saedis Saevarsdottir
    Thorunn A. Olafsdottir
    Erna V. Ivarsdottir
    Gisli H. Halldorsson
    Kristbjorg Gunnarsdottir
    Asgeir Sigurdsson
    Ari Johannesson
    Jon K. Sigurdsson
    Thorhildur Juliusdottir
    Sigrun H. Lund
    Asgeir O. Arnthorsson
    Edda L. Styrmisdottir
    Julius Gudmundsson
    Gerdur M. Grondal
    Kristjan Steinsson
    Lars Alfredsson
    Johan Askling
    Rafn Benediktsson
    Ragnar Bjarnason
    Arni J. Geirsson
    Bjorn Gudbjornsson
    Hallgrimur Gudjonsson
    Haukur Hjaltason
    Astradur B. Hreidarsson
    Lars Klareskog
    Ingrid Kockum
    Helga Kristjansdottir
    Thorvardur J. Love
    Bjorn R. Ludviksson
    Tomas Olsson
    Pall T. Onundarson
    Kjartan B. Orvar
    Leonid Padyukov
    Bardur Sigurgeirsson
    Vinicius Tragante
    Kristbjorg Bjarnadottir
    Thorunn Rafnar
    Gisli Masson
    Patrick Sulem
    Daniel F. Gudbjartsson
    Pall Melsted
    Gudmar Thorleifsson
    Gudmundur L. Norddahl
    Unnur Thorsteinsdottir
    Ingileif Jonsdottir
    Kari Stefansson
    Nature, 2020, 584 : 619 - 623
  • [36] FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease
    Saevarsdottir, Saedis
    Olafsdottir, Thorunn A.
    Ivarsdottir, Erna V.
    Halldorsson, Gisli H.
    Gunnarsdottir, Kristbjorg
    Sigurdsson, Asgeir
    Johannesson, Ari
    Sigurdsson, Jon K.
    Juliusdottir, Thorhildur
    Lund, Sigrun H.
    Arnthorsson, Asgeir O.
    Styrmisdottir, Edda L.
    Gudmundsson, Julius
    Grondal, Gerdur M.
    Steinsson, Kristjan
    Alfredsson, Lars
    Askling, Johan
    Benediktsson, Rafn
    Bjarnason, Ragnar
    Geirsson, Arni J.
    Gudbjornsson, Bjorn
    Gudjonsson, Hallgrimur
    Hjaltason, Haukur
    Hreidarsson, Astradur B.
    Klareskog, Lars
    Kockum, Ingrid
    Kristjansdottir, Helga
    Love, Thorvardur J.
    Ludviksson, Bjorn R.
    Olsson, Tomas
    Onundarson, Pall T.
    Orvar, Kjartan B.
    Padyukov, Leonid
    Sigurgeirsson, Bardur
    Tragante, Vinicius
    Bjarnadottir, Kristbjorg
    Rafnar, Thorunn
    Masson, Gisli
    Sulem, Patrick
    Gudbjartsson, Daniel F.
    Melsted, Pall
    Thorleifsson, Gudmar
    Norddahl, Gudmundur L.
    Thorsteinsdottir, Unnur
    Jonsdottir, Ingileif
    Stefansson, Kari
    NATURE, 2020, 584 (7822) : 619 - +
  • [37] STRUCTURAL-ANALYSIS OF HUMAN AND MURINE FLT3 LIGAND GENOMIC LOCI
    LYMAN, SD
    STOCKING, K
    DAVISON, B
    FLETCHER, F
    JOHNSON, L
    ESCOBAR, S
    ONCOGENE, 1995, 11 (06) : 1165 - 1172
  • [38] Multiple forms of mRNA for human flt3 ligand in fetal liver.
    Zhou, S
    Mao, N
    Liu, Y
    Tang, PH
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 384 - 384
  • [39] FLT3 in human hematologic malignancies
    Kiyoi, H
    Naoe, T
    LEUKEMIA & LYMPHOMA, 2002, 43 (08) : 1541 - 1547
  • [40] Cloning and overexpression of human TRPA1 in the yeast Pichia pastoris
    Moparthi, L.
    Survery, S.
    Zygmunt, P.
    Johanson, U.
    FEBS JOURNAL, 2011, 278 : 120 - 120